InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Discover the complete record of transactions filed by FLESHNER NEIL E., Directeur Médical. Director active across 1 company, notably POINT Biopharma Global Inc.. Cumulatively, 5 disclosures have been recorded. Breakdown: 0 buy · 1 sell. Total volume traded: €4m. Activity tracked since 25 May 2022. The latest transaction was filed on 31 October 2023 (Don). Regulator: SEC (Form 4). All data is openly available.
5 of 5 declarations
Fleshner Neil E. is the Chief Medical Officer at POINT Biopharma Global Inc. In this role, he is responsible for the medical strategy and research initiatives of the company. His expertise in the medical field allows him to lead innovative projects aimed at improving treatments for patients. He plays a key role in the development of new therapies.